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ABSTRACT
Background: Intracranial space-occupying lesions can be caused by a variety of disease processes, ranging from 
neoplasms to non-neoplastic lesions including hematomas, abscesses and vascular malformations. This article provides 
an overview of varied clinical presentations of patients with intracranial space-occupying lesions.Methods:A total of 
200 cases of intracranial space-occupying lesions presenting at Neuro Clinic and Care were retrospectively analyzed. 
Adult patients from all age groups and both genders were included in this study. Results: 165 patients (82.5%) had 
neoplastic lesions while 35 (17.5%) had non-neoplastic lesions. Metastatic lesions from primary tumor elsewhere in the 
body comprised the most common group with81 cases (40.5%), followed by meningiomas with 27 cases (13.5%). 
Males were affected slightly more than females (1:0.8). The most common presenting symptom was headache 87 
patients (43.5%,) followed by focal symptoms such as numbness, tingling or weakness being present in 80 (40%)and 
seizures observed in 65 (32.5%).Conclusion: The study reviews the wide range of symptoms the patients with intracra-
nial space-occupying lesions present with, the most common being headache, followed by focal symptoms such as 
numbness, tingling or weakness, seizures and vomiting. Knowledge of these typical as well as atypical patterns of clinical 
presentation can aid physicians in timely detection and prompt application of diagnostic and therapeutic modalities.
Key Words: Intracranial space-occupying lesions, Primary brain tumors, Clinical presentation.
O R I G I N A L  A R T I C L E
INTRODUCTION
The term “intracranial space-occupying lesion” refers to 
neoplasms as well as non-neoplastic lesions. 
Neoplasms may be benign or malignant and primary or 
metastatic. Non-neoplastic lesions include hematomas, 
cerebral abscesses including Toxoplasmosis, cysts 
including arachnoid cysts, colloid cysts, dermoid cysts, 
epidermoid cysts, vascular malformations and inflam-
matory or parasitic masses such as cerebral Amoebiasis 
and cystecercosis within cranial cavity (1) .Primary malig-
nant tumors of the central nervous system (CNS) 
account for approximately 2% of all the primary tumors 
of the human body (2, 3). Considerable regional and racial 
variations play a role in the difference in the incidence 
and pattern of intracranial neoplastic  space-occupying 
lesions (SOL) throughout the world (1).  In most studies 
reported from Asian countries, brain tumors occurred 
mostly during 4th decade of life while in Western coun-
tries, during 5th and 6th decades of life (4-13). Incidence 
of brain tumors in the U.S. is 10 per 100,000 
person-years, with a male-female ratio of 6:4 (14).Primary 
brain tumors are classified on the basis of their histolog-
ical appearance and cellular orign(3). Primary brain 
tumors can be classified as gliomas or non-gliomas. 
Gliomas account for >80% of primary brain tumors and 
include astrocytomas, oligodendrogliomas, ependymo-
mas and mixed oligodendroglial and astrocytic tumors. 
Non-gliomas comprise of benign tumors such as menin-
giomas and pituitary adenomas as well as malignant 
tumors such as medulloblastomas, primary CNS 
lymphomas and CNS germ cell tumors. The most 
common benign brain tumors are meningiomas, 
comprising about 20% of primary brain tumors. Astrocy-
tomas including Glioblastoma multiforme (GBM) are the 
most common malignant brain tumors (2,3). Almost half 
of the brain tumors are primary and the remaining are 
metastases that have originated outside the CNS. Brain 
metastases are more common than primary malignant 
brain tumors and are usually multiple (14). The most 
common tumor metastasizing to brain is carcinoma lung 
followed by carcinoma breast, colonic carcinoma 
and malignant melanoma. Patients with intracranial 
space-occupying lesions can present with signs and 
symptoms that can be generalized or focal (Table 1). 
Focal symptoms are due to localized brain damage and 
presentation may indicate location of lesion. These 
symptoms include weakness, somatosensory loss, visual 
Table 1: Presenting Symptoms & Signs in Patients with Intracranial
Space-Occupying Lesions 
False 
Localizing &
Lateralizing
Signs  
Headache CN lesions
Nausea,
Vomiting
Horner's
Syndrome 
Seizures Cerebellar
signs 
Personality
changes 
Change in 
mental status
Memory loss
Motor deficits
Sensory 
deficits
Deficits of 
speech or 
vision 
Papilledema
Cerebello-pontine angle 
(Acoustic neuroma):
Ipsilateral deafness
Tinnitus
Nystagmus
Ipsilateral cerebellar signs
Facial and Trigeminal palsies
Pituitary tumors:Endocrine symptoms
Visual defects 
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Occipital Lobe :
Contralateral hemianopia
Frontal Lobe :
Personality changes
Hemiparesis
Expressive aphasia
Anosmia
Temporal Lobe:
Behavioral changes
Depersonalization
Hallucinations
Quadrantanopia
Complex partial or generalized
seizures 
Localizing Signs & Symptoms
Cerebellum:
Ataxia
Dysmetria
Nystagmus
Generalized
Signs &
Symptoms  
Parietallobe:
Spatial disorientation
Hemisensory loss
Receptive aphasia
Hemianopia 
loss or aphasia and tend to occur in the initial stages of 
disease. Generalized symptoms occur as the tumor size 
increases and/or when intracranial pressure (ICP) rises. 
These symptoms include headache, nausea, vomiting, 
seizures, neurocognitive symptoms, personality changes 
and false localizing signs (3,15-18). Large lesions in some 
locations in the brain (silent regions) may remain 
relatively quiescent while a small lesion in dominant 
hemisphere may drastically impair speech. A 
space-occupying lesion in CNS may infiltrate and 
destroy important structures. It can impair cerebrospinal 
fluid (CSF) flow causing hydrocephalus or it can induce 
formation of new blood vessels leading to vasogenic 
edema. In rare instances, intracranial lesions can manifest 
with unusual symptoms that range from syncopal 
attacks, vertigo, and vestibular neuritis to local symptoms 
such as sensory seizures (15), dermatomal hypoesthesia, 
ulnar neuropathy (15), trigeminal neuralgia (19) and even 
Parkinsonism (20). Physicians could err in their diagnosis 
and in formulating treatment plans because of these 
unusual presentations.This study aims to enhance the 
knowledge regarding the varied clinical presentations of 
intracranial space-occupying lesions in adult patients to 
allow early diagnosis and prompt treatment. To the best 
of our knowledge, current study is one of the few studies 
conducted in Pakistan regarding the frequency of intrac-
ranial space-occupying lesions and the first study from 
Pakistan demonstrating the spectrum of clinical 
presentation of intracranial space-occupying lesions in 
adults.
METHODOLOGY
The study was carried out retrospectively in which data 
from a total of 200 patients with intracranial space- 
occupying lesions; having been collected over a period 
of 14 years was reviewed during four months from April 
2014 to August 2014 at Neuro Clinic and Care, Karachi, 
Pakistan. Adult patients from all ages and both genders 
were included in the study. Diagnosis of intracranial 
space-occupying lesion was made by either histological 
examination (biopsy) or radiological examination (com-
puted tomography or magnetic resonance imaging).Data 
was entered and saved onto SPSS version 20. Before 
analyzing; data was checked and corrected for any 
possible error in data entry. Separate frequency and 
valid percentages were calculated for main categorical 
variables.
RESULTS
A total of 200 cases of intracranial space-occupying 
lesions presenting at Neuro Clinic and Care were retro-
spectively analyzed. Adult patients from all age groups 
and both genders were included in this study. The mean 
age of respondents was 50 (SD +/- 2) years. Male 
patients constituted 56% (111) and females were 45% 
(89), giving a male/female ratio of 1:0.8.Figure 1 shows 
that out of 200 cases of intracranial space-occupying 
lesions, 82.5% (n=165) were neoplasms, most 
common of which were brain metastases (40.5%, 
n=81). Meningiomas ranked second with 27 cases 
(13.5%) while undifferentiated gliomas (12%, n=24) 
were third in frequency. Astrocytomas accounted for 
9.5% (n=19) cases and oligodendrogliomas were 3% 
(n=6). Acoustic neuromas (Schwannomas) and pituitary 
tumors each constituted 2% (n=4) of the lesions. 
Among the 17.5% (n=35) cases of non-neoplastic 
lesions, the most common was tuberculomas (11%, 
n=22) followed by brain abscesses (2%, n=4), 
neurocysticercosis and toxoplasmosis, each being 0.5% 
(n=1). Fungal granulomas, arteriovenous malformations 
and nasopharyngeal mass eroding base of skull 
comprised 3.5% of cases (n=7). As depicted in Table 2, 
of all the 200 cases of intracranial space-occupying 
lesions, the most common clinical presentation was 
headache (43.5%, n=87) which was characterized in 
most cases as constant, progressive over a period of 
weeks or months and moderate to severe in intensity. 
Focal symptoms such as numbness, tingling and weakness 
occurred in 40% of cases (n=80). Seizures ranked third 
in frequency with 32.5% of cases (n=65) and vomiting 
occurred in 27.5% of cases (n=55). Speech deficit and 
loss of vision or diplopia ranked fifth and sixth in frequen-
cy with 15% (n=30) and 13.5% (n=27) cases respec-
tively. 12% of the patients (n=24) had gait disturbances 
while 10.5% (n=21) had dizziness. Urine incontinence 
was found in 7% of the patients (n=14). Progressive 
decline in cognitive functions occurred in 6.5% (n=13) 
patients and personality changes were found in 4% 
(n=8) of the cases. 3.5% of the cases( of acoustic 
neuroma); (n=7) had hearing deficits while only 1% 
(n=2) had loss of smell. None of the patients was found 
to have loss of taste. Other symptoms such as drowsiness, 
unconsciousness, repeated falls, tinnitus, weight loss, 
neck pain, dysphagia, generalized weakness and fever 
occurred in 52.5% of the patients (n=105). While 
evaluating the patients, motor deficits were found to be 
the most common presenting sign (Table 3) with 92.5% 
of the patients (n=185) showing an increase in tone 
and/or a decrease in power, demonstrating signs of 
upper motor neuron lesions. Gait disturbances including 
heel and toe walking were found in more than half of the 
cases (52.5%, n=105). Sensory impairment in pain, 
touch, temperature and/or deep pressure sensations 
that evaluates integrity of anterior/lateral columns was 
found in 2.5% of the patients (n=5) while sensory 
impairment in position and vibration sensations evaluating 
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Figure 1: Distribution of 200 cases of intracranial space-occupying lesions
the integrity of posterior column occurred in 14% 
(n=28). Cerebellar signs such as nystagmus, positive 
finger-nose and heel-shin tests and impaired rapid 
alternating movements were present in 24% 
(n=48).Level of consciousness was impaired in a quarter 
of the patients (25%, n=50) with 27.5% of the patients 
(n=55) not oriented to person, place and/or time. Memory 
impairment was found in 36.5% of the cases (n=73) 
and higher cortical functions that were evaluated by serial 
sevens and calculations were also impaired in 36.5% 
(n=73). Speech impairment was present in 13.5% of 
the cases (n=27). Loss of smell occurred in 1.5% 
(n=3). Cranial nerve II impairment demonstrated by 
compromised visual acuity, visual fields and by fundoscopic 
examination showing papilledema was found in 32% 
(n=64). Pupillary response and extraoccular muscle 
movements were impaired in 12% of the patients 
(n=24). Facial sensations, corneal reflex and Masseter’s 
bulk and power (demonstrating integrity of cranial nerve 
V) were impaired in 2.5% (n=5) while cranial nerve VII 
evaluated by checking facial movements was impaired in 
24.5% (n=49). Cranial nerve VIII was evaluated by 
hearing tests (Rinne and Weber ) and was found to be 
impaired in 6.5% (n=13). Gag reflex assessing cranial 
nerves IX and X was absent in 6% of the cases (n=12). 
Only 2 patients (1%) had impaired active and passive 
neck movements showing compromised function of 
cranial nerve XI while tongue mass and movements 
demonstrating intactness of cranial nerve XII were 
impaired in 1.5% of the patients (n=3).
DISCUSSION
Both neoplastic and non-neoplastic intracranial 
space-occupying lesions share features of clinical 
presentation. In a study involving 100 cases of intracranial 
space occupying lesions conducted in Lahore, 
Pakistan,(1) neoplastic lesions comprised 89% of the 
cases while non-neoplastic lesions were reported to be 
11%, which gives a similar proportion as in our study of 
200 cases comprising of 82.5% neoplastic and 17.5% 
non-neoplastic lesions. Males were affected slightly 
more than females in their study giving a sex ratio of 1.7: 
1, which correlates with the results of our study.  
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SYMPTOMS  n %
Headache  87 43.5%
Seizures  65 32.5%
Vomiting  55 27.5%
Dizziness
Progressive decline in 
 21 10.5%
cognitive functions  
13 6.5%
Speech deficit  30 15%
Personality changes  8 4% 
Focal signs/symptoms  80 40%
Loss of smell  2 1%
Loss of vision / Diplopia 27 13.5%
Loss of taste  0 0%
Hearing deficits  7 3.5%
Gait disturbances  24 12%
Urine incontinence  14 7%
Others (drowsiness,
disorientation, 
unconsciousness,
repeated falls, tinnitus,
weight loss, neck pain, 
dysphagia, generalized
weakness, fever)     
105 52.5%
SIGNS
 
n
 
%
 
Impaired consciousness 50 25%
 
Not oriented to person, place and/or
time 55 27.5%
 
Impaired memory
 
73 36.5%
 
Impaired higher cortical functions
 
73 36.5%
 
Impaired speech
 
27 13.5%
 
CN I:Impaired sense of Smell  
 
3 1.5%
 
CN II: Papilledema,abnormalities in
visual acuity and visual fields  
  
64 32%
 
CN III, IV, VI:Restricted Extraoccular
muscle movements and Abnormal
pupillary reflexes   
 
24 12%
 
CN V: Facial sensation, corneal reflex,
masseter ’s bulk & powerimpairment  
  
5 2.5%
 
CN VII: Impaired Facial movements
 
49 25%
 
CN VIII: Hearing Abnormalities (tested
Weber and Rinne) 
 
13 6.5%
 CN IX, X:Abscent gag reflex
 
12 6%
 CN XI:Impaired neck movements 
 
2 1%
 CN XII:Abnormalities of tongue mass
and movements  
 
3 1.5%
 
Motor deficits  185 92.5% 
Sensory deficits–Anterior/Lateral
column (pain, temperature, touch, deep
pressure)   
 
 
5 2.5% 
Sensory deficits–Posterior column
(position, vibration)   28
14% 
Cerebellar signs
Gait disturbances
48 24% 
105 52.5% 
Table 3: Frequency of different clinical signs of 
intracranial space-occupying lesions
Table 2: Frequency of different clinical symptoms 
of intracranial space-occupying lesions 
Headache, the most common presenting symptom in 
our study, occurred in 43.5% of the patients.  Buckner 
et al. pointed out that the new onset of headache that is 
constant, progressive, severe, especially worse in the 
morning and occurs in association with nausea, vomiting 
or focal neurological deficits is more characteristic of an 
intracranial space-occupying lesion (2). In patients with 
pre-existing headaches, a change in the prior headache 
pattern or an increase in their frequency or intensity 
suggests presence of an intracranial mass (2, 21).Headache 
often occurred in association with other symptoms, 
including nausea and vomiting (27.5% of the patients), 
visual disturbances (13.5%), gait disturbances( 12%) 
and dizziness (10.5%).In a retrospective study of 111 
patients conducted by Forsyth and Posner, headaches 
were present in 48% of the patients with primary and 
metastatic brain tumors, which gives a similar proportion 
as in our study. Most headaches (77%) were tension-type 
headache while only some were migraine-type (9%) (21). 
Some locations are more likely to produce headaches, 
for example, infratentorial and intraventricular tumors 
were found to cause headache more frequently than a 
supratentorial tumor, as a result of impaired CSF flow 
causing hydrocephalus and raised ICP resulting in 
midline shift (22 ,23) Rapidly growing tumors are more 
often associated with headache than slow-growing 
tumors. A study that analyzed signs and symptoms of 
279 patients with brain tumors pointed out that in only 
1/3rd of the patients the site of the tumor coincided with 
the lateralization of headache (23).In our study, seizure 
activity occurred in 32.5% of the patients which is 
similar in frequency to a study conducted in US by Chan-
dana and Movva (3). Seizure activity has been reported in 
various studies to be more common in patients with 
low-grade gliomas (2,3,15,16). Location of the space-occu-
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pying lesion may determine the type of seizure and asso-
ciated neurologic symptoms.Progressive decline in 
cognitive functions as the presenting symptom in 
patients with intracranial space-occupying lesions 
occurred in 6.5%. Cognitive dysfunction includes changes 
in memory, orientation, higher cortical functions and speech. 
Personality changes were reported in 4% of the patients. 
According to Chandana and Movva, symptoms of cognitive 
dysfunction are more likely to herald the presence of an 
intracranial lesion in dominant hemisphere than in 
non-dominant hemisphere (3). Focal symptoms including 
motor and sensory deficits such as numbness, tingling and 
weakness was found in 40% of the patients. Patients with 
intracranial space-occupying lesions can manifest with 
unusual symptoms ranging from syncope attacks, vertigo, 
vestibular neuritis, dermatomal hypoesthesia, psychiatric 
symptoms to local signs such as sensory seizures and 
entrapment neuropathy. Our study demonstrated some 
interesting symptoms that patients with intracranial SOLs 
may present with.  These include loss of smell (1%), hearing 
deficits (3.5%) and speech deficits (15%). Similarly, trigeminal 
neuralgia has been reported as the initial manifestation of 
temporal glioma. The patients presented with episodic, 
lancinating facial pain. These intracranial supratentorial 
gliomas occurred especially in young patients.19In our 
study, functions of trigeminal nerve such as facial 
sensations, corneal reflex and Masseter’s bulk and power 
were impaired in 2.5% (n=5).Because Glioblastoma Multi-
forme (GBM) is the most common primary brain tumor, it 
has presented in a number of unusual ways such as ulnar 
neuropathy, vertigo and syncopal attacks (16), musicogenic 
epilepsy and reflex epilepsy (24-26), pseudo-foreign language 
syndrome (27, 28), unusual pain syndrome (28) and unusual 
personality changes e.g. hypersexuality and anorexia nervosa 
(27,29,30). GBM of the pineal gland( which is extremely rare at 
this location), has been reported to present with hydroceph-
alus due to compression of the aqueduct of Sylvius and 
visual disturbances e.g. horizontal nystagmus and CN VI 
palsy (31).Parkinsonism has also been described as a 
presenting feature of intracranial space-occupying lesions. 
Tumors that infiltrate or compress striatum or substantia 
nigra may present with features of Parkinsonism. 
Meningiomas are the most common histological type that 
can present with it, particularly those with a supratentorial 
localization (20).Intracerebral schwannomas, in our study, 
made up 2% of all intracranial space-occupying lesions. 
These tumors commonly presented with seizures, headache, 
nystagmus, tinnitus, hearing loss, facial or trigeminal 
palsies.  In rare instances, this tumor has been reported to 
present as classic temporal lobe epilepsy (33-36).Intracranial 
space-occupying lesions can also present with central pain. 
Patients with meningioma, low-grade astrocytoma, brain 
abscess or arteriovenous malformation causing central pain 
due to compression of parietal cortex have been reported in 
literature. Thalamic tumors have also been reported as a 
cause of central pain (37).
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